Home › Funds › Ilex Capital Partners (UK) LLP › SYK
Ilex Capital Partners (UK) LLP position in SYK
STRYKER CORPORATION · Health Care
Ilex Capital Partners (UK) LLP reported holding 239,210 shares of SYK (STRYKER CORPORATION) in its Q3 2026 13F filing — a position valued at US$65.9M, representing 1.28% of its reported portfolio and ranking #24 among its reported holdings. Ilex Capital Partners (UK) LLP has disclosed SYK holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Ilex Capital Partners (UK) LLP's SYK position evolved
Ilex Capital Partners (UK) LLP first disclosed a stake in SYK in Q2 2025 at 133,652 shares (US$52.9M). The position peaked in Q2 2026 at 399,898 shares, worth US$125.9M. Across 6 filings, Ilex Capital Partners (UK) LLP increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 239,210 shares valued at US$65.9M — a reduction of -160,688 shares quarter over quarter.. Notable position changes include a 39% increase in Q3 2025 (shares fell 5% over the following quarter), a 98% increase in Q2 2026 (shares fell 13% over the following quarter), a 40% trim in Q3 2026 (shares rose 12% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 133.65K | $52.88M | New |
| Q3 2025 | 185.75K | $68.67M | Add |
| Q4 2025 | 239.86K | $84.30M | Add |
| Q1 2026 | 201.56K | $66.23M | Reduce |
| Q2 2026 | 399.90K | $125.90M | Add |
| Q3 2026 | 239.21K | $65.88M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SYK and 13F data
SYK (STRYKER CORPORATION) is a Health Care company. 23 other funds we track also report a position in SYK — the largest reported positions include GREENLEAF TRUST (US$4.17B), PRICE T ROWE ASSOCIATES INC /MD/ (US$3.75B), JPMorgan Chase & Co (US$3.42B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SYK
- GREENLEAF TRUST 15.16M sh · $4.17B · Q3 2026
- PRICE T ROWE ASSOCIATES INC /MD/ 11.92M sh · $3.75B · Q2 2026
- JPMorgan Chase & Co 12.28M sh · $3.42B · Q3 2026
- Wellington Management Group 8.17M sh · $2.57B · Q2 2026
- WELLINGTON MANAGEMENT GROUP LLP 8.17M sh · $2.57B · Q2 2026
- ALLIANCEBERNSTEIN L.P. 4.93M sh · $1.62B · Q2 2026
- Arrowstreet Capital 3.28M sh · $1.03B · Q2 2026
- First Western Trust Bank 3.02M sh · $949.98M · Q2 2026
- Fundsmith LLP 2.91M sh · $917.39M · Q2 2026
More on Ilex Capital Partners (UK) LLP
FAQ
How long has Ilex Capital Partners (UK) LLP held SYK?
Ilex Capital Partners (UK) LLP has disclosed SYK holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
What is Ilex Capital Partners (UK) LLP's current position in SYK?
As of Q3 2026, Ilex Capital Partners (UK) LLP holds 239.21K shares of SYK (STRYKER CORPORATION), valued at $65.88M, representing 1.28% of its reported portfolio and ranking #24.
Has Ilex Capital Partners (UK) LLP been buying or selling SYK?
In the latest 13F filing (Q3 2026), Ilex Capital Partners (UK) LLP reduced its position in SYK. The position peaked in Q2 2026 at 399.90K shares.
Which other funds hold SYK?
Other major institutional holders of SYK include GREENLEAF TRUST, PRICE T ROWE ASSOCIATES INC /MD/, JPMorgan Chase & Co, among 23 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.